Wow, that's assuming Lympro ever gets off the ground. The AMBS narrative keeps changing and not for the better. I thought Gerald has stated a while back they had enough cash on hand until the end of 2015? Am I mistaken?

And did you see that DNDN just filed for Ch.11 protection? People need to remember nothing is a guaranteed success in biopharma.